Carlsmed has filed a notice of an exempt offering of securities to raise $52,499,996.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Carlsmed is raising up to $52,499,996.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Michael Cordonnier played a key…
